#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic mastocytosis Round cell liposarcoma Retinal artery occlusion Anaplastic large cell lymphoma T- and null-cell types Immunodeficiency Systemic lupus erythematosus Haemophilia A with anti factor VIII Fragile X syndrome Undifferentiated sarcoma Acute respiratory distress syndrome Angiosarcoma metastatic Mucopolysaccharidosis I Cerebral amyloid angiopathy Hereditary angioedema with C1 esterase inhibitor deficiency Bile acid synthesis disorder More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent Andersen-Tawil syndrome – Basic Information Marginal zone lymphoma refractory – Basic Information Synovial sarcoma – Basic Information Hereditary motor and sensory neuropathy – Treatment Friedreich’s ataxia – Life with Disease Uterine leiomyosarcoma – Trials in Disease Alagille syndrome – Diagnostics Pleural mesothelioma malignant – Life with Disease Amyotrophic lateral sclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alemtuzumab Aficamten Obexelimab FOSMANOGEPIX Dabrafenib Istaroxime Imatinib Bupropion Hydrochloride Acetylsalicylic Acid Ph. Eur. ANERATRIGINE MESILATE S227928 Avutometinib Tirzepatide Asfotase Alfa Sodium Lactate Solution Bimatoprost Incb099280 CHONDROITIN SULFATE SODIUM Lutetium (177Lu) Edotreotide Phenazone More therapies…

    Learn about Your Condition

    BRAF gene mutation Supraventricular tachycardia Varicella Indolent systemic mastocytosis Mixed dementia Arthralgia Short-bowel syndrome End stage renal disease Uveal melanoma Medullary thyroid cancer Rectosigmoid cancer Chronic myeloid leukaemia Leukaemia Phenylketonuria Biopsy heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Upadacitinib for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Sulfasalazine
    • Ciprofloxacin
    • Dexamethasone
    Belgium Bulgaria France Greece Italy Poland +1

  • Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    The Netherlands

  • Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

    Recruiting

    2 1
    Investigated Drugs:
    • Human Glucagon-Like Peptide-2 Analogue Linked To A Human Immunoglobulin Fc Fragment
    Belgium Denmark France Germany Poland

  • Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Siponimod
    Italy

  • Study on NECVAX-NEO1 and Paclitaxel Albumin-Bound for Patients with Triple-Negative Breast Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Necvax-Neo1
    • Paclitaxel Albumin-Bound
    Germany

  • Study on the Effectiveness and Safety of Naxitamab for Patients with Refractory Ewing’s Sarcoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Naxitamab
    Poland
Previous Page
1 … 332 333 334 335 336 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!